Literature DB >> 25785121

Up-regulated Reg proteins induced by Interleukin-22 treatment ameliorate acute liver injury in rat model.

Hong-Bin Zhang1, Hong-Chun Luo2, Xiao-Juan Xin2, Ai-Zhong Zeng2.   

Abstract

BACKGROUND: The regenerating gene (Reg), encoding lectin-related protein, was originally isolated from a rat regenerating pancreatic islets. Interleukin-22 (IL-22), a recently identified cytokine, is produced by Th 17 cells and natural killer cells. Both of them have been shown to play an important role in controlling tissue repair. But, it is unclear whether the IL-22/Reg axis is involved in liver regeneration and the improvement of liver function in a rat model of acute liver injury. AIMS: We investigated the expression levels of Reg proteins after IL-22 stimulation in a rat model of acute liver injury, and estimated the effects of Reg proteins ameliorating acute liver injury.
METHODS: Western blot was used to measure the expressions of Reg I, Reg III, Reg IV proteins after treatment with recombinant lentivirus IL-22. At the same time, the expression levels of TB, ALT, AST, endotoxin (ETM), superoxide dismutase (SOD), malondialdehyde (MDA) were detected by related reagents.
RESULTS: In a rat model of acute liver injury, the expression levels of Reg I, Reg III, Reg IV proteins were increased after treatment with IL-22 recombinant lentivirus compared with treatment with lentivirus-empty vector, especially, Reg IV protein expression. Meanwhile, treatment with IL-22 recombinant lentivirus reduced serum levels of TB, ALT, AST, ETM, and decreased MAD levels in rat liver tissues, but increased SOD levels in rat liver tissues.
CONCLUSION: IL-22 stimulation enhanced the expressions of Reg proteins in liver cell, especially, Reg IV protein, and ameliorated liver injury in a rat model of acute liver injury. Reg protein, especially Reg IV protein, might act as a biological mediator of immune cell-derived IL-22 in the recovering mechanism of liver injury.

Entities:  

Keywords:  Reg protein; interleukin-22 (IL-22); liver injury; liver regeneration

Year:  2015        PMID: 25785121      PMCID: PMC4358576     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  36 in total

1.  Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rbeta ) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes.

Authors:  S V Kotenko; L S Izotova; O V Mirochnitchenko; E Esterova; H Dickensheets; R P Donnelly; S Pestka
Journal:  J Biol Chem       Date:  2000-10-16       Impact factor: 5.157

2.  IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro.

Authors:  Stephan Brand; Julia Dambacher; Florian Beigel; Kathrin Zitzmann; Malte H J Heeg; Thomas S Weiss; Thomas Prüfer; Torsten Olszak; Christian J Steib; Martin Storr; Burkhard Göke; Helmut Diepolder; Manfred Bilzer; Wolfgang E Thasler; Christoph J Auernhammer
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-01-04       Impact factor: 4.052

3.  IL-22 is involved in liver regeneration after hepatectomy.

Authors:  Xiaodan Ren; Bin Hu; Lisa M Colletti
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-10-29       Impact factor: 4.052

4.  Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor.

Authors:  Y Yamada; I Kirillova; J J Peschon; N Fausto
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

5.  A novel gene activated in regenerating islets.

Authors:  K Terazono; H Yamamoto; S Takasawa; K Shiga; Y Yonemura; Y Tochino; H Okamoto
Journal:  J Biol Chem       Date:  1988-02-15       Impact factor: 5.157

6.  HIP/PAP is an adhesive protein expressed in hepatocarcinoma, normal Paneth, and pancreatic cells.

Authors:  L Christa; F Carnot; M T Simon; F Levavasseur; M G Stinnakre; C Lasserre; D Thepot; B Clement; E Devinoy; C Brechot
Journal:  Am J Physiol       Date:  1996-12

7.  Possible role of REG Ialpha protein in ulcerative colitis and colitic cancer.

Authors:  A Sekikawa; H Fukui; S Fujii; A Nanakin; N Kanda; Y Uenoyama; T Sawabu; H Hisatsune; T Kusaka; S Ueno; H Nakase; H Seno; T Fujimori; T Chiba
Journal:  Gut       Date:  2005-05-24       Impact factor: 23.059

8.  Targeted inhibition of gene expression of pancreatitis-associated proteins exacerbates the severity of acute pancreatitis in rats.

Authors:  H Zhang; E Kandil; Y-Y Lin; G Levi; M E Zenilman
Journal:  Scand J Gastroenterol       Date:  2004-09       Impact factor: 2.423

9.  IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration.

Authors:  Stephan Brand; Florian Beigel; Torsten Olszak; Kathrin Zitzmann; Sören T Eichhorst; Jan-Michel Otte; Helmut Diepolder; Andreas Marquardt; Wolfgang Jagla; Andreas Popp; Stéphane Leclair; Karin Herrmann; Julia Seiderer; Thomas Ochsenkühn; Burkhard Göke; Christoph J Auernhammer; Julia Dambacher
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-04       Impact factor: 4.052

10.  REG Ialpha protein mediates an anti-apoptotic effect of STAT3 signaling in gastric cancer cells.

Authors:  Akira Sekikawa; Hirokazu Fukui; Shigehiko Fujii; Kazuhito Ichikawa; Shigeki Tomita; Johji Imura; Tsutomu Chiba; Takahiro Fujimori
Journal:  Carcinogenesis       Date:  2007-11-16       Impact factor: 4.944

View more
  3 in total

1.  Inhibition of hepatic cells pyroptosis attenuates CLP-induced acute liver injury.

Authors:  Yuan-Li Chen; Guo Xu; Xiao Liang; Juan Wei; Jing Luo; Guan-Nan Chen; Xiao-Di Yan; Xue-Ping Wen; Ming Zhong; Xin Lv
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

Review 2.  REG4 promotes the proliferation and anti-apoptosis of cancer.

Authors:  Hua-Chuan Zheng; Hang Xue; Cong-Yu Zhang
Journal:  Front Cell Dev Biol       Date:  2022-09-12

Review 3.  Interleukin 22 in Liver Injury, Inflammation and Cancer.

Authors:  Ye Wu; Jie Min; Chang Ge; Jinping Shu; Di Tian; Yuan Yuan; Dian Zhou
Journal:  Int J Biol Sci       Date:  2020-06-29       Impact factor: 6.580

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.